Article Versions Notes

Parmar KR, Lukka PB, Wagh S, Temrikar ZH, Liu J, Lee RE, Braunstein M, Hickey AJ, Robertson GT, Gonzalez-Juarrero M, et al. Development of a Minimalistic Physiologically Based Pharmacokinetic (mPBPK) Model for the Preclinical Development of Spectinamide Antibiotics. Pharmaceutics. 2023; 15(6):1759. https://doi.org/10.3390/pharmaceutics15061759

Parmar, Keyur R., Pradeep B. Lukka, Santosh Wagh, Zaid H. Temrikar, Jiuyu Liu, Richard E. Lee, Miriam Braunstein, Anthony J. Hickey, Gregory T. Robertson, Mercedes Gonzalez-Juarrero, and et al. 2023. "Development of a Minimalistic Physiologically Based Pharmacokinetic (mPBPK) Model for the Preclinical Development of Spectinamide Antibiotics" Pharmaceutics 15, no. 6: 1759. https://doi.org/10.3390/pharmaceutics15061759

Parmar, K. R., Lukka, P. B., Wagh, S., Temrikar, Z. H., Liu, J., Lee, R. E., Braunstein, M., Hickey, A. J., Robertson, G. T., Gonzalez-Juarrero, M., Edginton, A., & Meibohm, B. (2023). Development of a Minimalistic Physiologically Based Pharmacokinetic (mPBPK) Model for the Preclinical Development of Spectinamide Antibiotics. Pharmaceutics, 15(6), 1759. https://doi.org/10.3390/pharmaceutics15061759